21 results
8-K
EX-99.1
CADL
Candel Therapeutics Inc
19 May 23
Regulation FD Disclosure
9:15am
years (27 - 74) Sex, n (%) Female 21 (51%) 3 (33%) 24 (48%) Male 20 (49%) 6 (67%) 26 (52%) Race, n (%) White 38 (93%) 8 (89%) 46 (92%) Black or African … Baseline Clinical effect on injected tumor and uninjected tumor Day 168 Day 280 Day 0 Black hole within tumor image is injection site106 PFU dose 56 YOM
8-K
EX-99.1
2b52k32zxl2n0t4cpvy
6 Dec 22
Regulation FD Disclosure
8:01am
DEF 14A
9aunsv 0cohyg2
2 Sep 22
Definitive proxy
8:30am
8-K
EX-99.1
1qab3cyhqtqmb
6 Jun 22
Regulation FD Disclosure
8:37am
10-K
w5vi0p 2j
29 Mar 22
Annual report
8:46am
10-Q
jy186mfv eds
8 Sep 21
Quarterly report
8:37am
424B4
gyy1w1 kwcxzlpu6
28 Jul 21
Prospectus supplement with pricing info
4:02pm
S-1/A
523sk1h
16 Jul 21
IPO registration (amended)
6:07am
S-1
hy4ufomiy49j313ccho
25 Jun 21
IPO registration
5:28pm